Evidence map›Paper›PMID 20920184›Full record

ArticleBMC microbiology2010

Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.

Rachel Balder, Serena Lipski, John J Lazarus, William Grose, Ronald M Wooten, Robert J Hogan, Donald E Woods, Eric R Lafontaine

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trigger Factor inJournal of bacteriology · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Prophages Present inPHAGE (New Rochelle, N.Y.) · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Modeled Structure of the Cell Envelope Proteinase ofFrontiers in bioengineering and biotechnology · 2020
    Article
  19. Identification ofFrontiers in microbiology · 2020
    Article
  20. An Evolutionary Arms Race BetweenFrontiers in microbiology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Rachel BalderDepartment of Infectious Diseases, University of Georgia College of Veterinary Medicine, Athens, GA 30602, USA.
Serena Lipski
John J Lazarus
William Grose
Ronald M Wooten
Robert J Hogan
Donald E Woods
Eric R Lafontaine
University of Toledo Medical Center · USUniversity of Georgia · USUniversity of Calgary · CA

Funding

Dysregulation of Innate Immune Responses by Borrelia burgdorferi:A Role for IL-10R01AI073452 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI WOOTEN, RONALD MARK · 2008 to 2011
$1.5M
Identification of B. pseudomallei &B. mallei adhesinsR21AI062775 · NIAID · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI LAFONTAINE, ERIC R · 2005 to 2006
$585k
NIAID NIH HHS AI062775NIAID NIH HHS R01 AI073452
6 · The paper itself

Abstract

backgroundBurkholderia pseudomallei and Burkholderia mallei cause the diseases melioidosis and glanders, respectively. A well-studied aspect of pathogenesis by these closely-related bacteria is their ability to invade and multiply within eukaryotic cells. In contrast, the means by which B. pseudomallei and B. mallei adhere to cells are poorly defined. The purpose of this study was to identify adherence factors expressed by these organisms.

resultsComparative sequence analyses identified a gene product in the published genome of B. mallei strain ATCC23344 (locus # BMAA0649) that resembles the well-characterized Yersinia enterocolitica autotransporter adhesin YadA. The gene encoding this B. mallei protein, designated boaA, was expressed in Escherichia coli and shown to significantly increase adherence to human epithelial cell lines, specifically HEp2 (laryngeal cells) and A549 (type II pneumocytes), as well as to cultures of normal human bronchial epithelium (NHBE). Consistent with these findings, disruption of the boaA gene in B. mallei ATCC23344 reduced adherence to all three cell types by ~50%. The genomes of the B. pseudomallei strains K96243 and DD503 were also found to contain boaA and inactivation of the gene in DD503 considerably decreased binding to monolayers of HEp2 and A549 cells and to NHBE cultures.A second YadA-like gene product highly similar to BoaA (65% identity) was identified in the published genomic sequence of B. pseudomallei strain K96243 (locus # BPSL1705). The gene specifying this protein, termed boaB, appears to be B. pseudomallei-specific. Quantitative attachment assays demonstrated that recombinant E. coli expressing BoaB displayed greater binding to A549 pneumocytes, HEp2 cells and NHBE cultures. Moreover, a boaB mutant of B. pseudomallei DD503 showed decreased adherence to these respiratory cells. Additionally, a B. pseudomallei strain lacking expression of both boaA and boaB was impaired in its ability to thrive inside J774A.1 murine macrophages, suggesting a possible role for these proteins in survival within professional phagocytic cells.

conclusionsThe boaA and boaB genes specify adhesins that mediate adherence to epithelial cells of the human respiratory tract. The boaA gene product is shared by B. pseudomallei and B. mallei whereas BoaB appears to be a B. pseudomallei-specific adherence factor.

Indexed as

Adhesins, BacterialAmino Acid SequenceAnimalsBurkholderia malleiBurkholderia pseudomalleiCell LineEpithelial CellsFemaleGene Expression Regulation, BacterialGenes, BacterialHumansMiceMice, Inbred BALB CMolecular Sequence DataSequence Analysis, DNASpecies SpecificityAdhesins, Bacterial

Identifiers

PMID20920184
PMCPMC2955633
OpenAlexW2163750401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.